{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:40:02Z","timestamp":1756316402554,"version":"3.44.0"},"reference-count":31,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,7,8]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>This is the case of a parameningeal alveolar rhabdomyosarcoma (ARMS) in a 13-year-old boy who presented with painless loss of vision in the right eye, but very few other physical signs. The ARMS diagnosis was confirmed with imaging and molecular characterisation of the tumour. Despite tolerating the initial chemotherapy and radiotherapy regimens, there was leptomeningeal recurrence and the patient unfortunately passed away. Parameningeal ARMS occurs in an area of the body, which leads to a wide variety of possible presenting symptoms, creating a long list of differentials that can delay treatment. This tumour subtype has a poor prognosis, and due to the location of the tumour around vital structures in the head, treatment toxicities must be taken into account. This highlights the necessity for having a strong index of suspicion for this tumour in atypical presentations in children, and the necessity for prompt treatment to prevent leptomeningeal disease from occurring.<\/jats:p>","DOI":"10.1136\/bcr-2021-243267","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:36:47Z","timestamp":1626352607000},"page":"e243267","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Parameningeal alveolar rhabdomyosarcoma in a child"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-7500","authenticated-orcid":false,"given":"Abhinav","family":"Kumar","sequence":"first","affiliation":[{"name":"Medical School, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Pothula","sequence":"additional","affiliation":[{"name":"ENT Department, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"2025082710023930000_14.7.e243267.1","doi-asserted-by":"crossref","unstructured":"Dasgupta R , Fuchs J , Rodeberg D . Rhabdomyosarcoma. Semin Pediatr Surg 2016.","DOI":"10.1053\/j.sempedsurg.2016.09.011"},{"key":"2025082710023930000_14.7.e243267.2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24465"},{"key":"2025082710023930000_14.7.e243267.3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11912-012-0243-y","article-title":"Current state-of-the-art systemic therapy for pediatric soft tissue sarcomas","volume":"14","author":"Ray","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"2025082710023930000_14.7.e243267.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","article-title":"Rhabdomyosarcoma","volume":"5","author":"Skapek","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025082710023930000_14.7.e243267.5","unstructured":"Fletcher CDM , Bridge JA , Hogendoorn P . WHO classification of tumours of soft tissue. In: WHO Classif tumours soft tissue bone. 4 edn, 2013."},{"key":"2025082710023930000_14.7.e243267.6","doi-asserted-by":"crossref","DOI":"10.2310\/7070.2005.4091","article-title":"Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan","volume":"35","author":"Meazza","year":"2006","journal-title":"J Otolaryngol"},{"key":"2025082710023930000_14.7.e243267.7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jcms.2017.03.005","article-title":"Rhabdomyosarcoma of the maxillofacial region in children and adolescents: report of 9 cases and literature review","volume":"45","author":"Iatrou","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"2025082710023930000_14.7.e243267.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70246-6"},{"key":"2025082710023930000_14.7.e243267.9","doi-asserted-by":"crossref","unstructured":"Wasti AT , Mandeville H , Gatz S , et al . Rhabdomyosarcoma. paediatrics and child health (United Kingdom), 2018.","DOI":"10.1016\/j.paed.2018.03.001"},{"key":"2025082710023930000_14.7.e243267.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2007.11.001"},{"key":"2025082710023930000_14.7.e243267.11","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3182a92d0d"},{"key":"2025082710023930000_14.7.e243267.12","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12421"},{"key":"2025082710023930000_14.7.e243267.13","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.1.15"},{"key":"2025082710023930000_14.7.e243267.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.03.137"},{"key":"2025082710023930000_14.7.e243267.15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biocel.2014.05.003","article-title":"Micrornas and epigenetic mechanisms of rhabdomyosarcoma development","volume":"53","author":"Cie\u015bla","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"2025082710023930000_14.7.e243267.16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.4-1-34","article-title":"Rhabdomyosarcoma: an overview","volume":"4","author":"Dagher","year":"1999","journal-title":"Oncologist"},{"key":"2025082710023930000_14.7.e243267.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.11.909"},{"key":"2025082710023930000_14.7.e243267.18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2020.01.035","article-title":"Patterns of failure in Parameningeal alveolar rhabdomyosarcoma","volume":"107","author":"Bradley","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025082710023930000_14.7.e243267.19","doi-asserted-by":"publisher","DOI":"10.2174\/156800908785699333"},{"key":"2025082710023930000_14.7.e243267.20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071758","article-title":"Recent advances and challenges in the treatment of rhabdomyosarcoma","volume":"12","author":"Miwa","year":"2020","journal-title":"Cancers"},{"key":"2025082710023930000_14.7.e243267.21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(18)30337-1","article-title":"Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"19","author":"Bisogno","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025082710023930000_14.7.e243267.22","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S1470-2045(19)30617-5","article-title":"Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Bisogno","year":"2019","journal-title":"Lancet Oncol"},{"key":"2025082710023930000_14.7.e243267.23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt426"},{"key":"2025082710023930000_14.7.e243267.24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clon.2017.04.034","article-title":"The evolving role of proton beam therapy for sarcomas","volume":"29","author":"Frisch","year":"2017","journal-title":"Clin Oncol"},{"key":"2025082710023930000_14.7.e243267.25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cancers6010112","article-title":"Proton radiotherapy for pediatric sarcoma","volume":"6","author":"Ladra","year":"2014","journal-title":"Cancers"},{"key":"2025082710023930000_14.7.e243267.26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2014.08.033","article-title":"A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study","volume":"113","author":"Ladra","year":"2014","journal-title":"Radiother Oncol"},{"key":"2025082710023930000_14.7.e243267.27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2019.08.005","article-title":"Outcome and patterns of relapse in childhood Parameningeal rhabdomyosarcoma treated with proton beam therapy","volume":"105","author":"Doyen","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025082710023930000_14.7.e243267.28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MPH.0000000000001188","article-title":"Excessive treatment failures in patients with parameningeal rhabdomyosarcoma with reduced-dose cyclophosphamide and delayed radiotherapy","volume":"40","author":"Lucas","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025082710023930000_14.7.e243267.29","unstructured":"NCT02567435. combination chemotherapy with or without temsirolimus in treating patients with intermediate risk rhabdomyosarcoma, 2015. Available: https:\/\/clinicaltrials.gov\/show\/NCT02567435"},{"key":"2025082710023930000_14.7.e243267.30","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1259"},{"key":"2025082710023930000_14.7.e243267.31","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26710","article-title":"Central nervous system relapse of rhabdomyosarcoma","volume":"65","author":"De","year":"2018","journal-title":"Pediatr Blood Cancer"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-243267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:02:51Z","timestamp":1756314171000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-243267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,15]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bcr-2021-243267"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-243267","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}